![](https://www.webhealthnetwork.com/img/webhealth-logo.png)
Paresis - 146 Studies Found
Terminated |
: The HAM Infliximab Study : HTLV-I-associated Myelopathy : 2009-01-14 : Drug: Infliximab Infliximab 3mg/kg infused intravenously at weeks 0, 2 and 8 and then every 8 weeks unti |
Terminated |
: Safety and Efficiency Study of Valproic Acid In HAM/TSP : HTLV-I-Associated Myelopathy : 2007-08-20 : Drug: Valproic Acid Valproic acid by oral route (20mg/Kg/day) during one year. |
Recruiting |
: Prospective Cohort Follow-up of French Patients With Profound and Multiple Disabilities: Healthcare Pathways and Quality of Life Among Patients and Their Families :
|
Completed |
: Zidovudine Plus Lamivudine in HTLV-I-associated Myelopathy: a Randomised Trial : HTLV-I-associated Myelopathy : 2006-01-04 : Drug: Zidovudine/lamivudine |
Enrolling by invitation |
: Dual Algorithm Post Market Clinical Study :
|
Enrolling by invitation |
: Evaluation of the MP Diagnostics HTLV Blot 2.4 :
|
Completed |
: Physiologic Studies of Spasticity :
: 2001-04-17 |
Completed |
: Nuclear Magnetic Spectroscopy Imaging to Evaluate Primary Lateral Sclerosis, Hereditary Spastic Paraplegia and Amyotrophic Lateral Sclerosis :
|
Completed |
: MRI Brain Studies in Patients With HTLV-1 Associated Myelopathy/Tropical Spastic Paraparesis : Tropical Spastic Paraparesis : 2002-05-01 |
Not yet recruiting |
: Effect of Raltegravir in Patients With Acute Tropical Spastic Paraparesis - Human T-Lymphotropic Virus 1 Infection :
: 2015-11-16 : Drug: "Raltegravir" and "Zidovudine" Through measure of pro-viral load and clinical |